Genomic Testing Cooperative Liquid Trace

Genomic Testing Cooperative has launched Liquid Trace, a liquid biopsy assay that tests for both cell-free DNA and cell-free RNA. The test is currently available for clinical trials and pharma services and will be available for clinical use by Sept. 1, according to the company. GTC said that this improves the assay's sensitivity and provides transcriptome data that is enriched by various tumor markers (CA125, CA 15-3, CEA, etc.), making it possible to perform liquid immunoprofiling by evaluating levels of CD19, CD20, CD33, CD4, CD8, etc.)